Benefits
Iron metabolism and red blood cell formation
Copper-dependent ceruloplasmin is essential for converting iron (Fe2+) to the form (Fe3+) that can be loaded onto transferrin for transport. Without adequate copper, iron builds up in tissues but cannot be mobilized for red blood cell production, which is why copper deficiency can cause anemia even when iron levels look normal. This describes what goes wrong when copper is missing. It is not evidence that extra copper helps someone whose intake is already adequate.
Copper-zinc superoxide dismutase (SOD)
Copper-zinc superoxide dismutase (Cu/Zn-SOD) is a primary intracellular antioxidant enzyme, neutralizing superoxide radicals in the cytoplasm. Copper is required for this enzyme to function. That is laboratory biology, not a measured outcome: none of the studies cited on this page measured antioxidant status, oxidative stress markers, or any related health outcome in people taking copper.
Connective tissue and bone health
Copper is required for lysyl oxidase, an enzyme that cross-links collagen and elastin fibers in bone, cartilage, skin, and blood vessels. When copper is genuinely deficient, connective tissue weakness and bone fragility can develop. Nothing cited on this page tested copper supplements for bone, joint or cartilage outcomes in people whose copper intake is already adequate.
Neurological function
Copper is a cofactor for dopamine β-hydroxylase (norepinephrine synthesis) and peptidylglycine α-amidating monooxygenase (neuropeptide activation). Severe copper deficiency can cause nerve and spinal cord problems that resemble vitamin B12 deficiency. This is documented in a Mayo Clinic review of copper deficiency myelopathy and in individual case reports, in people who had become deficient, most often from high-dose zinc or after gut surgery. It is not a reason for someone with a normal diet to take copper.
Mechanism of action
Ceruloplasmin-mediated iron mobilization
Ceruloplasmin, a copper-containing protein, functions as a ferroxidase — oxidizing ferrous iron (Fe2+) to ferric iron (Fe3+) that can be loaded onto transferrin. This step is rate-limiting for iron export from storage cells and is why copper deficiency causes functional iron deficiency despite normal iron stores.
Cytochrome c oxidase activity
Copper is a core component of cytochrome c oxidase (Complex IV) — the terminal enzyme in the mitochondrial electron transport chain. Complex IV transfers electrons to oxygen, completing cellular respiration and ATP production. Copper deficiency impairs mitochondrial energy production.
Melanin and collagen crosslinking
Tyrosinase (melanin synthesis) and lysyl oxidase (collagen/elastin crosslinking) are both copper-dependent enzymes. Copper deficiency results in depigmentation and structurally weakened connective tissues — evidenced in the severe connective tissue disease Menkes syndrome caused by genetic copper transport defects.
Clinical trials
A review of copper nutrition, biochemistry and human physiology (Collins 2021, Adv Food Nutr Res, PMID 34112357). It is a narrative review of existing research, not a trial in people.
Not applicable. This is a review of published research, not a study that gave copper to people.
The review sets out copper's known roles in the body: ceruloplasmin acting on iron, lysyl oxidase cross-linking collagen and elastin, and other copper-dependent enzymes. It also notes that outright copper deficiency appears to be more common than once thought, and that the blood tests used to detect marginal copper status are not good enough. Because it is a review, it did not test copper supplements, and no study cited on this page shows a benefit from extra copper in people who already get enough.
Systematic review of published case reports of blood problems caused by too much zinc (Dutta et al. 2026, Biol Trace Elem Res). It pooled 37 individual cases drawn from 34 publications between 1972 and 2025. Case reports are the weakest form of evidence, and pooling them together does not turn them into a controlled trial.
37 people described in case reports published between 1972 and 2025. Zinc came from oral supplements, from zinc-containing denture adhesive creams, and in some cases from swallowed coins. Daily elemental zinc ranged from about 50 mg to more than 1,500 mg, taken over weeks to years.
Anemia was present in nearly all cases, usually alongside low white blood cell counts, and the most severe or longest exposures caused drops across all blood cell lines. Serum copper was low in every patient. People recovered when zinc was stopped and copper was replaced. The proposed mechanism is that zinc switches on a protein called metallothionein in the gut lining, which binds copper and blocks it from being absorbed. Two things are worth noting: the low end of the range, around 50 mg of zinc a day, is only slightly above the 40 mg adult upper limit, so this is not only an extreme-megadose problem; and nerve damage from copper deficiency does not always fully reverse, so a fixed zinc-to-copper ratio should not be treated as a proven safeguard.